Provided by Tiger Trade Technology Pte. Ltd.

Precigen

4.07
-0.0550-1.33%
Volume:780.37K
Turnover:3.24M
Market Cap:1.44B
PE:-2.96
High:4.34
Open:4.28
Low:4.02
Close:4.12
52wk High:5.47
52wk Low:1.12
Shares:353.82M
Float Shares:205.00M
Volume Ratio:0.52
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3727
EPS(LYR):-1.3727
ROE:-571.97%
ROA:-44.30%
PB:68.78
PE(LYR):-2.96

Loading ...

Press Release: Precigen Reports Full Year 2025 Financial Results and Business Updates

Dow Jones
·
Mar 26

Precigen Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Mar 24

Earning Preview: Precigen this quarter’s revenue is expected to increase by 513.75%, and institutional views are bullish

Earnings Agent
·
Mar 18

Precigen to host full-year 2025 results conference call

Reuters
·
Mar 12

Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

THOMSON REUTERS
·
Mar 12

Is PGEN’s PAPZIMEOS Exclusivity Quietly Redefining Its Competitive Moat in Rare Disease Therapy?

Simply Wall St.
·
Jan 14

Precigen Highlights PAPZIMEOS Launch Success at J.P. Morgan Healthcare Conference

Reuters
·
Jan 12

Director and 10% Owner Randal J. Kirk Reports Sale of Precigen Inc. Common Shares

Reuters
·
Dec 23, 2025

Precigen Director Jeffrey B. Kindler Reports Sale of Common Shares

Reuters
·
Dec 17, 2025

Precigen (PGEN): Valuation in Focus After FDA Approval and Strengthened Cash Position

Simply Wall St.
·
Nov 29, 2025

Can Precigen's (PGEN) Revenue Surge Offset Concerns About Its Expanding Losses?

Simply Wall St.
·
Nov 27, 2025

Director and 10% Owner Randal J. Kirk Reports Disposal of Precigen Inc. Common Shares

Reuters
·
Nov 22, 2025

US High Growth Tech Stocks to Watch in November 2025

Simply Wall St.
·
Nov 17, 2025

Stock Track | Precigen Soars 5.96% as H.C. Wainwright Raises Price Target to $9

Stock Track
·
Nov 14, 2025

Precigen Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 14, 2025

Precigen price target raised to $9 from $8.50 at H.C. Wainwright

TIPRANKS
·
Nov 14, 2025

Precigen reports Q3 EPS ($1.06) vs. (9c) last year

TIPRANKS
·
Nov 14, 2025

Precigen Q3 Loss Widens, Revenue Rises

MT Newswires Live
·
Nov 14, 2025

Biopharmaceutical company Precigen Q3 net loss widens

Reuters
·
Nov 14, 2025

Earnings Flash (PGEN) Precigen Posts Q3 Loss Per Share $1.06, vs. FactSet Est of $0.09 Loss, If Comparable

MT Newswires Live
·
Nov 14, 2025